Molbio Diagnostics IPO listing: listed at ₹980, +21.4% over the issue price
Molbio Diagnostics listed on NSE, BSE on 17 Aug 2026 at ₹980 per share, +₹173 (+21.4%) against the upper price band of ₹807. The issue (price band ₹807, bidding 10 Aug 2026 to 12 Aug 2026) was subscribed 70.27x overall. The last grey-market premium we captured before listing was ₹127 on 16 Aug 2026 (daily average of 13 quotes), which implied a listing price of ₹934; the shares listed at ₹980, ₹46 above that.
Updated 6 Oct 2026, 19:02 IST. Dated dealer references.
Listing day facts
| Listing date | 17 Aug 2026 |
|---|---|
| Exchange | NSE, BSE |
| Listing price | ₹980 |
| Upper price band (issue price basis) | ₹807 |
| Gain or loss vs upper band | +₹173 per share (+21.4%) |
| Price band | ₹807 |
| Issue dates | 10 Aug 2026 to 12 Aug 2026 |
| Subscription (overall, at close) | 70.27x, as of 12 Aug 2026 |
| Lot size | 18 shares |
| Gain or loss per lot vs upper band | +₹3,114 |
Grey-market premium against the actual listing
The last grey-market premium we captured before listing was ₹127 on 16 Aug 2026 (daily average of 13 quotes), which implied a listing price of ₹934; the shares listed at ₹980, ₹46 above that.
| Date | GMP | Implied listing price | Actual listing vs implied | Quotes captured |
|---|---|---|---|---|
| 5 Aug 2026 | ₹80 | ₹887 | +₹93 (+10.5%) | 2 |
| 6 Aug 2026 | ₹196 | ₹1,003 | −₹23 (−2.3%) | 11 |
| 7 Aug 2026 | ₹189 | ₹996 | −₹16 (−1.6%) | 13 |
| 8 Aug 2026 | ₹146 | ₹953 | +₹27 (+2.8%) | 12 |
| 9 Aug 2026 | ₹127 | ₹934 | +₹46 (+4.9%) | 12 |
| 10 Aug 2026 | ₹129 | ₹936 | +₹44 (+4.7%) | 11 |
| 11 Aug 2026 | ₹127 | ₹934 | +₹46 (+4.9%) | 13 |
| 12 Aug 2026 | ₹144 | ₹951 | +₹29 (+3.0%) | 12 |
| 13 Aug 2026 | ₹155 | ₹962 | +₹18 (+1.9%) | 14 |
| 14 Aug 2026 | ₹139 | ₹946 | +₹34 (+3.6%) | 13 |
| 15 Aug 2026 | ₹119 | ₹926 | +₹54 (+5.8%) | 11 |
| 16 Aug 2026 | ₹127 | ₹934 | +₹46 (+4.9%) | 13 |
GMP is unofficial and unregulated; these are the quotes our desk feed captured, averaged by day. Only the price band and the exchange listing price are official.
Frequently asked questions
What was the Molbio Diagnostics IPO listing price?
Molbio Diagnostics listed on NSE, BSE on 17 Aug 2026 at ₹980 per share.
How did Molbio Diagnostics list against the issue price?
The listing price of ₹980 was +₹173 per share (+21.4%) against the upper price band of ₹807.
What did the grey market indicate before Molbio Diagnostics listed?
The last grey-market premium we captured before listing was ₹127 on 16 Aug 2026 (daily average of 13 quotes), which implied a listing price of ₹934; the shares listed at ₹980, ₹46 above that. GMP is unofficial and not a forecast.
Where do Molbio Diagnostics shares trade now?
On NSE, BSE. Check the exchange for the current quote; BuyUnlistedShares tracks unlisted shares and does not quote listed prices.
Molbio Diagnostics IPO overview · GMP history · Subscription status · Allotment status
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP, in the market since 2002. Reviewed by the BuyUnlistedShares desk before publishing. Data as of 06 Oct 2026.
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Ask · Community · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
Part of the Gayatri Financial Synergy group (gayatrifin.com): AMFI-registered mutual fund distributor, Faridabad, since 2002.
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
